Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

46
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
46
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

51
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
51
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

97
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
97
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

30
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
30
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

35
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
35
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

34
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
34

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: Interventions against disability in frail older adults: Lessons learned from clinical trials.

The journal of nutrition, health & aging·2026
Same author

Corrigendum to "Current and investigational medications for the treatment of sarcopenia" [Metabolism 2023;149:155597].

Metabolism: clinical and experimental·2026
Same author

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2025
Same author

Periparturient mortality in merino ewes in Australia: Incidence, impact and the path to mitigation strategies.

Australian veterinary journal·2025
Same author

Editorial: ICOPE Healthy Longevity Integrative Preventive Care, Alzheimer's Disease Prevention and Early Diagnosis.

The journal of prevention of Alzheimer's disease·2024
Same author

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2024

Related Experiment Video

Updated: Oct 23, 2025

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
10:19

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

14.4K

International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines.

M Izquierdo1, R A Merchant, J E Morley

  • 1Mikel Izquierdo, PhD, Department of Health Sciences, Public University of Navarra, Av. De Barañain s/n 31008 Pamplona (Navarra) Spain, Tel + 34 948 417876 mikel.izquierdo@gmail.com.

The Journal of Nutrition, Health & Aging
|August 19, 2021
PubMed
Summary

Regular physical activity (PA) and structured exercise significantly attenuate age-related declines in physical function and prevent chronic diseases in older adults. Exercise is a potent therapeutic agent, optimizing health and functional capacity across the lifespan.

Keywords:
Sarcopeniadiseasesexercisefallsfrailfunctional capacitymulticomponent training

More Related Videos

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
07:27

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Published on: October 6, 2016

10.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.1K

Related Experiment Videos

Last Updated: Oct 23, 2025

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease
10:19

Getting to Compliance in Forced Exercise in Rodents: A Critical Standard to Evaluate Exercise Impact in Aging-related Disorders and Disease

Published on: August 22, 2014

14.4K
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
07:27

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty

Published on: October 6, 2016

10.4K
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

1.1K

Area of Science:

  • Gerontology and Exercise Science
  • Integrative physiology of aging
  • Preventive and therapeutic exercise interventions

Background:

  • Human aging is characterized by universal physiological decline, exacerbated by sedentary lifestyles, leading to reduced muscle function, cardiorespiratory fitness, and independence.
  • Physical activity (PA) and structured exercise are crucial in mitigating age-related functional impairments and preventing chronic diseases like cardiovascular disease, diabetes, and osteoporosis.
  • Exercise interventions demonstrably improve frailty markers and cognitive function, optimizing functional capacity in older adults.

Framework:

  • Exercise is viewed as a therapeutic agent, requiring evidence-based dosing and individualization akin to pharmacological treatments.
  • Prescription of PA/structured exercise should align with intended outcomes, including primary prevention, fitness enhancement, or disease treatment.
  • Exercise therapy offers a multifaceted approach, often targeting multiple physiological systems simultaneously, unlike single-outcome pharmacological interventions.

Implementation:

  • Exercise can serve as an alternative to medication for conditions like depression, supporting deprescribing initiatives.
  • For conditions lacking effective drug therapies, such as sarcopenia and dementia, exercise plays a primary role in prevention and treatment.
  • This consensus statement provides an evidence-based rationale for exercise and PA in promoting health and managing diseases in older adults.

Implications:

  • Exercise prescription guidelines are discussed, detailing modalities and doses proven effective in randomized controlled trials for older adults.
  • Recommendations aim to address literature gaps and optimize exercise/PA as both preventative medicine and therapeutic intervention.
  • The findings support the integration of tailored exercise programs to enhance healthspan and functional independence in aging populations.